Pharsight

Elyea patents expiration

List of large molecules

Patent Number Company Patent Title Patent Expiry Activity Alert
USD961376 REGENERON PHARMACEUTICALS, INC. Packaging
Aug, 2040

(16 years from now)

US11439758 REGENERON PHARMACEUTICALS, INC. Devices and methods for precision dose delivery
Aug, 2040

(16 years from now)

US11433186 REGENERON PHARMACEUTICALS, INC. Devices and methods for precision dose delivery
Aug, 2040

(16 years from now)

USD961377 REGENERON PHARMACEUTICALS, INC. Packaging
Aug, 2040

(16 years from now)

US11472861 REGENERON PHARMACEUTICALS, INC. Methods for producing aflibercept in chemically defined media having reduced aflibercept variants
Aug, 2040

(16 years from now)

US11459374 REGENERON PHARMACEUTICALS, INC. Anti-VEGF protein compositions and methods for producing the same
Aug, 2040

(16 years from now)

US11459373 REGENERON PHARMACEUTICALS, INC. Anti-VEGF protein compositions and methods for producing the same
Aug, 2040

(16 years from now)

Ingredients: AFLIBERCEPT

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic